| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/19/2005 | US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders |
| 05/19/2005 | US20050106724 Self renewing dental follicle tissues for use in generating periodontal ligament like membrane structures; tissue repair and regenerative medicine |
| 05/19/2005 | US20050106695 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 05/19/2005 | US20050106679 Leptin proteins |
| 05/19/2005 | US20050106675 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/19/2005 | US20050106674 Ephrin receptor binding protein for use as tool in treatment and prevention of cell proliferative and nervous system disorders |
| 05/19/2005 | US20050106672 Neurotransmission associated proteins |
| 05/19/2005 | US20050106638 Immunoglobulin for use in diagnosis, prevention and treatment of fibrosis and scarring; antiscarring agents |
| 05/19/2005 | US20050106586 Detection of neurodegenerative diseases |
| 05/19/2005 | US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease |
| 05/19/2005 | US20050106272 Co-beadlet of dha and rosemary and methods of use |
| 05/19/2005 | US20050106266 docosahexaenoic acid and a calcium compound (carbonate, hydroxide,sulfate) |
| 05/19/2005 | US20050106235 Nsaid formulation comprising a granular composition and an extra-granular composition |
| 05/19/2005 | US20050106220 Administering gamma-aminobutyric acid receptor antagonist |
| 05/19/2005 | US20050106212 Using electrochemical mixture of metal compound and bioactive material; contacting substrate |
| 05/19/2005 | US20050106205 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
| 05/19/2005 | US20050106143 Collapsin response mediator protein; measurement of gene expression |
| 05/19/2005 | US20050106140 Antagonistic anti-hfas ligand human antibodies and fragments thereof |
| 05/19/2005 | US20050106127 Graft to humans; culture product; removing cells; preservation |
| 05/19/2005 | US20050106126 Compositions including ammonia oxidizing bacteria and methods of using same |
| 05/19/2005 | US20050106122 Absorption enhancing agent |
| 05/19/2005 | DE10148828B4 Modulation der Expression STAT-1-abhängiger Gene Modulating the expression of STAT-1-dependent genes |
| 05/19/2005 | CA2710829A1 Uses of adenosine a2a receptor antagonists |
| 05/19/2005 | CA2548538A1 Compositions and methods of use for a fibroblast growth factor |
| 05/19/2005 | CA2544900A1 Delta-9- the treatment of multiple sclerosis |
| 05/19/2005 | CA2544748A1 Allosteric modulators of metabotropic glutamate receptors |
| 05/19/2005 | CA2543045A1 Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof |
| 05/19/2005 | CA2542878A1 Dihydrobenzofuranyl alkanamine derivatives as 5ht2c agonists |
| 05/18/2005 | EP1530725A1 Materials and methods for inductions of immune tolerance |
| 05/18/2005 | EP1530632A2 Growth factor which acts through erb b-4 rtk |
| 05/18/2005 | EP1530573A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 05/18/2005 | EP1530570A2 CRISTALLINE ZIPRASIDONE HCl AND PROCESSES FOR PREPARATION THEREOF |
| 05/18/2005 | EP1530568A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE |
| 05/18/2005 | EP1530567A1 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 05/18/2005 | EP1530565A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 05/18/2005 | EP1530564A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 05/18/2005 | EP1530483A2 T cell receptor cdr3 sequences and methods for detection |
| 05/18/2005 | EP1530476A1 Use of reboxetine for the treatment of hot flashes |
| 05/18/2005 | EP1530473A2 Regulation of erythrocyte apoptosis |
| 05/18/2005 | EP1530469A2 Transdermal dosage form comprising an active agent and a salt and free-base form of an antagonist |
| 05/18/2005 | EP1530462A1 1-phenyl-2-dimethylaminomethyl cyclohexane compounds used for the therapy of depressive symptoms, pain, and incontinence |
| 05/18/2005 | EP1436381B1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 05/18/2005 | EP1430030B1 N-type calcium channel antagonists for the treatment of pain |
| 05/18/2005 | EP1404656B1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases |
| 05/18/2005 | EP1317430B1 (2-azabicyclo [2.2.1]hept-7-yl)methanol derivatives as nicotinic acetylcholine receptor agonists |
| 05/18/2005 | EP1301502B1 Compounds and their use as glycine transport inhibitors |
| 05/18/2005 | EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 05/18/2005 | EP1263724B1 Novel compounds |
| 05/18/2005 | EP1007050B1 Olanzapine for treating substance abuse |
| 05/18/2005 | CN1617884A Beta-amyloid binding factors and inhibitors thereof |
| 05/18/2005 | CN1617871A Purine derivatives as purinergic receptor antagonists |
| 05/18/2005 | CN1617865A Phenylalkynes |
| 05/18/2005 | CN1617862A Novel 1, 2, 4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/18/2005 | CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament |
| 05/18/2005 | CN1617855A Inhibitors of cytosolic phospholipase A2 |
| 05/18/2005 | CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/18/2005 | CN1617743A New pharmaceutical combinations for nos inhibitors |
| 05/18/2005 | CN1617736A Vaccine and method for treatment of motor neurone diseases |
| 05/18/2005 | CN1617732A Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 05/18/2005 | CN1617724A Neurotransmitter balance chemotherapy |
| 05/18/2005 | CN1617723A Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| 05/18/2005 | CN1617722A Nicotin-or isonicotin benzothiazole derivatives |
| 05/18/2005 | CN1617721A Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 05/18/2005 | CN1617719A Combination comprising a P-GP inhibitor and an anti-epileptic drug |
| 05/18/2005 | CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity |
| 05/18/2005 | CN1617715A Treating muscle wasting with selective androgen receptor modulators |
| 05/18/2005 | CN1617712A Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 05/18/2005 | CN1617711A Liposomal delivery of vitamin E based compounds |
| 05/18/2005 | CN1616459A Adenosine derivatives |
| 05/18/2005 | CN1616433A Carbamazepine medicine and its preparing method |
| 05/18/2005 | CN1616432A Compound, its use and pharmaceutical compositions comprising same |
| 05/18/2005 | CN1616431A Huperzine B bimolecular and double function group devicative, preparing method and its use |
| 05/18/2005 | CN1616425A Noval benzoindoline compounds, their preparing method and pharmaceutical composition containing them |
| 05/18/2005 | CN1616087A Nerve growth factor (NGF) liposome |
| 05/18/2005 | CN1616084A Botulinum toxin pharmaceutical compositions |
| 05/18/2005 | CN1616075A Chinese herbal medicine capsule for treating epilepsia |
| 05/18/2005 | CN1616053A Soft capsule containing medicine and its preparing method |
| 05/18/2005 | CN1616048A Medicine for treating epilepsia and its preparing method |
| 05/18/2005 | CN1616039A Sichuan aconite root freeze-dried powder injection and its preparing method |
| 05/18/2005 | CN1616027A Compound health tea |
| 05/18/2005 | CN1616026A Tea for treating insomnia and dreaminess |
| 05/18/2005 | CN1616023A Drug addiction stopping medicine |
| 05/18/2005 | CN1616020A Xingnaojing powder injection and preparing method |
| 05/18/2005 | CN1616005A Compound brain tonifying and intellect strengthening gastrodia tuber capsule |
| 05/18/2005 | CN1615992A Medicinal wine for quick acting and radically rheumatic arthritis and its preparing method |
| 05/18/2005 | CN1615981A Rhizoma alismatis new use discovered by toadstool choline M1 receptor prot-agonist screening technology |
| 05/18/2005 | CN1615973A Chinese medicine for treating facial paralysis, preparing method and use |
| 05/18/2005 | CN1615966A Cancer pain killing combined Chiese medicine |
| 05/18/2005 | CN1615962A Method for preparing night rest medicine and its solid preparation |
| 05/18/2005 | CN1615949A Medicine for treating epilepsia |
| 05/18/2005 | CN1615948A Medicine for treating mental disease |
| 05/18/2005 | CN1615941A Paste external use medicine for treating head ache |
| 05/18/2005 | CN1615940A Soporific Chinese medicine preparation and its preparing method |
| 05/18/2005 | CN1615935A Chinese medicine compound for promoting nerve regeneration |
| 05/18/2005 | CN1615873A Azaindoles compound |
| 05/18/2005 | CN1615867A Naloxone hydrchloride freeze-dried powder preparation for injection |
| 05/18/2005 | CN1615861A (1s, 2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylipiperidin-1-yl)-1-propanolmethanesulfonate trihydrate |
| 05/18/2005 | CN1615859A Nimodipine adhesive sheet |
| 05/18/2005 | CN1615840A Sodium camsylate freeze-dried powder injection preparation and its preparing method |
| 05/18/2005 | CN1615829A Use of sinapine in preparing medicine for preventing and curing senile dementia |